Lobbying Activity Report

1841-13672

Organization: Janssen Inc.
Associated registration: 1070-1841-22
Lobbying Activity date: 2021-10-27
Arranged a meeting: No
Posted date: 2021-11-15

In-house lobbyists who participated in the lobbying activity: Derek Badger
Senior Public Office Holders who were lobbied in this activity: Mitch Moneo, Assistant Deputy Minister
Pharmaceutical, Laboratory & Blood Services Division, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
British Columbia's Expensive Drugs for Rare Diseases (EDRD) program. Specifically the proposed delivery of a universal pharmacare program. Footnote1
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health Footnote1
Development of a joint industry-Government of British Columbia Life Sciences Sector Strategy Footnote1
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Economic Development and Trade, Health Footnote1
Special Authority Transformation (SAT project) Footnote1
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health Footnote1
Support British Columbia’s policy and regulatory framework to create a favourable business environment for the development of the life science sector. Footnote1
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Economic Development and Trade, Health, Science and Technology Footnote1
 
Senior officer who filed this Lobbying Activity Report: Jorge Bartolome
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.
Date Modified: